shutterstock_1231106194_pajor_pawel

Pajor Pawel / Shutterstock.com

14 September 2023FeaturesBiotechnologySarah Speight

UK universities prove resilience during Horizon hiatus

Before news broke last week of the new Horizon funding deal for the UK, IP law firm Mathys & Squire reported that the UK’s 50 biggest universities filed 433 new patent applications in the period 2021-2022.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

7 September 2023 The news that the UK will rejoin the €95.5 billion research fund has been met with widespread relief, but it’s a bittersweet story, finds Sarah Speight. Reaction from CMS, Arnold & Porter, Bird & Bird, HGF.

article

LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission

1 February 2021 The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.

More on this story

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

7 September 2023 The news that the UK will rejoin the €95.5 billion research fund has been met with widespread relief, but it’s a bittersweet story, finds Sarah Speight. Reaction from CMS, Arnold & Porter, Bird & Bird, HGF.

article

LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission

1 February 2021 The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.

More on this story

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

7 September 2023 The news that the UK will rejoin the €95.5 billion research fund has been met with widespread relief, but it’s a bittersweet story, finds Sarah Speight. Reaction from CMS, Arnold & Porter, Bird & Bird, HGF.

article

LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission

1 February 2021 The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.

More features

Moderna entities must face infringement suits, UPC rules

Baker McKenzie adds London partner with ‘enviable’ expertise

‘Keep calm and carry on’: UK+ regime stays post-Brexit

As AI shakes up pharma and biotech, can patent law keep up?

UK court clears the way for Amgen and Samsung to launch biosimilars

SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute

‘It’s going to be very different’: INTA CEO shares London meeting plans

INTA confirms London as host city for Annual Meeting 2026